X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $93,667.94 -3.47%
Ethereum $3,438.42 +2.71%
BNB $636.42 -3.18%
Optimism $2.33 +7.05%
Arbitrum $0.92 +9.61%
Solana $237.33 -5.45%
Polygon $0.56 -0.02%
Cosmos $7.97 -7.45%
Avalanche $42.14 +2.41%

Bitcoin $93,667.94 -3.47%
Ethereum $3,438.42 +2.71%
BNB $636.42 -3.18%
Optimism $2.33 +7.05%
Arbitrum $0.92 +9.61%
Solana $237.33 -5.45%
Polygon $0.56 -0.02%
Cosmos $7.97 -7.45%
Avalanche $42.14 +2.41%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed